U.S. Food and Drug Administration confirms date for Exact Sciences’ advisory committee

06-02-2014 Business Wire HealthComments (0)

Exact SciencesOncologyPharmaceuticalUSA

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the U.S. Food and Drug Administration has confirmed by notice in the Federal Register that its Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will review the premarket approval application (PMA) for the company’s Cologuard stool-DNA-based, non-invasive colorectal cancer screening test on March 27, 2014. The Federal Register notice can be found by clicking here. About Exact S

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top